"
Team:Goettingen/project overview/perspectives
From 2014.igem.org
(Difference between revisions)
m |
m |
||
| Line 14: | Line 14: | ||
<div class="proRP" id="rpart1"> | <div class="proRP" id="rpart1"> | ||
| - | <div id="goenext"><a id="prev"><img id="pButton"></a> | + | <div id="goenext"><a id="prev"><img id="pButton"></a> 12/15 <a id="next"><img id="nButton"></a></div> |
| Line 51: | Line 51: | ||
<br /><br /> | <br /><br /> | ||
| - | <div id="goenext"><a id="prev"><img id="pButton"></a> | + | <div id="goenext"><a id="prev"><img id="pButton"></a> 12/15 <a id="next"><img id="nButton"></a></div> |
<br /> | <br /> | ||
Revision as of 16:44, 26 September 2014
Project
Further perspectives
We have attained two milestones as far as the applications of our project is concerned. First,is the generation of peptides with an affinity to fungal surface molecules and second, is the proof of principle that our selection scheme can be used to generate peptides with affinity to a molecule under scrutiny. Both milestones hold promise but before that, we would like to elaborate on the future scope of the first milestone since it bears relevance to medicine and healthcare.
